Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
If you agree to take part in this study, you will complete 5 questionnaires during a
regularly scheduled visit. The questionnaires are designed to measure pain and other
symptoms, your mood, and your quality of life.
You will also give a tissue sample by inserting a cotton tipped swab into your mouth and
rubbing firmly against the inside of your cheek or underneath your lower or upper lip for
about 1 minute at the most.
Completing the 5 questionnaires and the swab sample should take about 30 minutes.
Length of Study:
After you complete the questionnaires and the swab sample collection, your active
participation in this study will be over.
This is an investigational study.
Up to 500 patients will take part in this study. All will be enrolled at MD Anderson.
Observational Model: Cohort, Time Perspective: Prospective
Association between inflammatory cytokines and development of treatment-related symptom burden in colorectal cancer patients
Xin Shelley Wang, MD. MPH
UT MD Anderson Cancer Center
United States: Institutional Review Board
|UT MD Anderson Cancer Center||Houston, Texas 77030|